logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9226964 B1

PDFFull Text
Expired
Date of Patent:
Jan. 05, 2016

Filed:

Jan. 03, 2014

Antibodies against epidermal growth factor receptor (egfr) and uses thereof

Applicant:

Merrimack Pharmaceuticals, Inc., Cambridge, MA (US);

Inventors:

Raghida Bukhalid, Melrose, MA (US);

Michael Feldhaus, Grantham, NH (US);

Anne King, Cambridge, MA (US);

Neeraj Kohli, Brighton, MA (US);

Eric Krauland, Lebanon, NH (US);

Jeffrey David Kearns, Arlington, MA (US);

Alexey A. Lugovskoy, Woburn, MA (US);

Ulrik Nielsen, Quincy, MA (US);

Assignee:

Merrimack Pharmaceuticals, Inc., Cambridge, MA (US);

Attorneys:

Nelson Mullins Riley & Scarborough LLP

Jane E. Remillard, Esq.

Jill Gorny Sloper, Esq.

Primary Examiner:

Michael Pak

Int. Cl.
CPC ...
C07K 16/00 (2006.01); A61K 39/395 (2006.01); C07K 16/28 (2006.01); G01N 33/74 (2006.01); C07K 16/32 (2006.01); C12Q 1/68 (2006.01); C07K 14/71 (2006.01); G01N 33/574 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39558 (2013.01); A61K 39/3955 (2013.01); C07K 16/2863 (2013.01); C07K 16/32 (2013.01); C12Q 1/686 (2013.01); G01N 33/74 (2013.01); A61K 2039/507 (2013.01); C07K 14/71 (2013.01); C07K 2317/34 (2013.01); C07K 2317/55 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); G01N 33/57484 (2013.01); G01N 2333/485 (2013.01); G01N 2800/52 (2013.01);
Abstract

Anti-EGFR antibodies, therapeutic compositions comprising combinations of anti-EGFR antibodies, as well as methods for using such antibodies and compositions to treat EGFR-related disorders (e.g., cancers), are disclosed.

Find Patent Forward Citations

Bukhalid, Raghida. (2016). Antibodies against epidermal growth factor receptor (egfr) and uses thereof (U.S. Patent No. 9226964). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9226964

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…